HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Gangwar Selected Research

N- (succinyl- beta- alanyl- L- leucyl- L- alanyl- L- leucyl)doxorubicin

11/2006Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin.
10/2001N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Gangwar Research Topics

Disease

2Neoplasms (Cancer)
11/2006 - 10/2001

Drug/Important Bio-Agent (IBA)

2N- (succinyl- beta- alanyl- L- leucyl- L- alanyl- L- leucyl)doxorubicinIBA
11/2006 - 10/2001
1EnzymesIBA
11/2006
1Sulfhydryl Compounds (Thiols)IBA
11/2006
1Conditioned Culture MediaIBA
11/2006
1ProdrugsIBA
10/2001